P1-227: Phase II study of sequential topoisomerase targeting regimens with irinotecan/oxaliplatin followed by etoposide/carboplatin in patients with extensive small cell lung cancer (SCLC)
2007
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI